{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:41:16Z","timestamp":1792320076652,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.canlet.2026.218880","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:07:46Z","timestamp":1792228066000},"page":"218880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Profiling circulating tumor DNA for recurrence prediction and prevention in hepatocellular carcinoma following liver transplantation"],"prefix":"10.1016","volume":"661","author":[{"given":"De-Zhen","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6776-5962","authenticated-orcid":false,"given":"Xiang-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia-Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Aye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu-Jun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Tao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Man","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2345-0736","authenticated-orcid":false,"given":"Yi-Feng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Wu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ren","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Bin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Rong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218880_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218880_bib2","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1158\/2159-8290.CD-21-0634","article-title":"Detecting liquid remnants of solid tumors: circulating tumor DNA minimal residual disease","volume":"11","author":"Moding","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218880_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrc.2017.125","article-title":"Targeting minimal residual disease: a path to cure?","volume":"18","author":"Luskin","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218880_bib4","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/s41556-018-0214-0","article-title":"Dormant tumour cells, their niches and the influence of immunity","volume":"20","author":"Goddard","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218880_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s43018-020-0043-5","article-title":"Circulating tumor DNA and liquid biopsy in oncology","volume":"1","author":"Cescon","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218880_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12943-019-1043-x","article-title":"Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA","volume":"18","author":"Ye","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218880_bib7","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2017.76.8671","article-title":"Circulating tumor DNA analysis in patients with cancer: American society of clinical oncology and college of American pathologists joint review","volume":"36","author":"Merker","year":"2018","journal-title":"J. Clin. Oncol. : Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218880_bib8","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.18.02052","article-title":"Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma","volume":"37","author":"Christensen","year":"2019","journal-title":"J. Clin. Oncol. : Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218880_bib9","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1158\/1078-0432.CCR-18-3663","article-title":"Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence","volume":"25","author":"Coombes","year":"2019","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218880_bib10","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/s41591-025-03577-y","article-title":"Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer","volume":"31","author":"Herbst","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218880_bib11","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.annonc.2024.08.2240","article-title":"Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY","volume":"35","author":"Kataoka","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2026.218880_bib12","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/s41591-024-03254-6","article-title":"ctDNA-based molecular residual disease and survival in resectable colorectal cancer","volume":"30","author":"Nakamura","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218880_bib13","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1158\/1078-0432.CCR-17-2899","article-title":"Adjuvant transarterial chemoembolization for HBV-related hepatocellular carcinoma after resection: a randomized controlled study","volume":"24","author":"Wang","year":"2018","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218880_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4240\/wjgs.v15.i1.19","article-title":"Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion","volume":"15","author":"Li","year":"2023","journal-title":"World J. Gastrointest. Surg."},{"key":"10.1016\/j.canlet.2026.218880_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.562103","article-title":"Potential role of adjuvant lenvatinib in improving disease-free survival for patients with high-risk hepatitis B virus-related hepatocellular carcinoma following liver transplantation: a retrospective, case control study","volume":"10","author":"Han","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218880_bib16","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1159\/000509424","article-title":"Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition)","volume":"9","author":"Zhou","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.canlet.2026.218880_bib17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E","article-title":"Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies","volume":"7","author":"Edmondson","year":"1954","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2026.218880_bib18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.canlet.2026.218880_bib19","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamaoncol.2019.0528","article-title":"Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer","volume":"5","author":"Reinert","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2026.218880_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.102908","article-title":"Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: a systematic review","volume":"135","author":"Galli","year":"2025","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2026.218880_bib21","article-title":"Evolving transplant oncology: evolving criteria for better decision-making","volume":"15","author":"Karageorgos","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.canlet.2026.218880_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17121930","article-title":"Updates on liquid biopsy and ctDNA in transplant oncology","volume":"17","author":"Loszko","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218880_bib23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22364","article-title":"Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution","volume":"545","author":"Abbosh","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218880_bib24","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1158\/1078-0432.CCR-19-1213","article-title":"Perioperative dynamic changes in circulating tumor DNA in patients with lung cancer (DYNAMIC)","volume":"25","author":"Chen","year":"2019","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218880_bib25","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1158\/1078-0432.CCR-18-3477","article-title":"Comprehensive liquid profiling of circulating tumor DNA and protein biomarkers in long-term Follow-Up patients with hepatocellular carcinoma","volume":"25","author":"Cai","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218880_bib26","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.ccell.2023.08.010","article-title":"Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer","volume":"41","author":"Chen","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218880_bib27","article-title":"Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancers","volume":"6","author":"Huffman","year":"2022","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.canlet.2026.218880_bib28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/jamaoncol.2023.0425","article-title":"Early detection of molecular residual disease and risk stratification for stage I to III colorectal cancer via circulating tumor DNA methylation","volume":"9","author":"Mo","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2026.218880_bib29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12072-023-10594-x","article-title":"Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer","volume":"18","author":"Huang","year":"2024","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.canlet.2026.218880_bib30","first-page":"118","article-title":"Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy","author":"Jin","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218880_bib31","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/jamaoncol.2019.3616","article-title":"Circulating Tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III Colon cancer","volume":"5","author":"Tie","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2026.218880_bib32","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1038\/s41467-021-27022-z","article-title":"Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC","volume":"12","author":"Qiu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218880_bib33","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/SLA.0000000000001866","article-title":"Liver resection and transplantation for patients with hepatocellular carcinoma beyond milan criteria","volume":"264","author":"Zaydfudim","year":"2016","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2026.218880_bib34","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/hep.30278","article-title":"Is it time to reconsider the Milan criteria for selecting patients with hepatocellular carcinoma for deceased-donor liver transplantation?","volume":"69","author":"Costentin","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218880_bib35","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1056\/NEJMoa2200075","article-title":"Circulating Tumor DNA analysis guiding adjuvant therapy in stage II Colon cancer","volume":"386","author":"Tie","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218880_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41591-022-02115-4","article-title":"Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer","volume":"29","author":"Kotani","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218880_bib37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-021-03642-9","article-title":"ctDNA guiding adjuvant immunotherapy in urothelial carcinoma","volume":"595","author":"Powles","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218880_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41698-026-01277-5","article-title":"Validation of a methylation-based, tissue-free MRD assay in colorectal cancer patients from the GALAXY study","volume":"10","author":"Nakamura","year":"2026","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.canlet.2026.218880_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002286","article-title":"Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: a prospective, observational, multicenter cohort study","volume":"14","author":"Sch\u00fctz","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.canlet.2026.218880_bib40","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00432-009-0584-6","article-title":"Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China","volume":"135","author":"Fan","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:15:07Z","timestamp":1792318507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526006440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"alternative-id":["S0304383526006440"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218880","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiling circulating tumor DNA for recurrence prediction and prevention in hepatocellular carcinoma following liver transplantation","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218880"}}